{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:38:42Z","timestamp":1760747922585,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jsbmb.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T11:01:58Z","timestamp":1477738918000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5\/6 nephrectomized rats"],"prefix":"10.1016","volume":"167","author":[{"given":"Kaichiro","family":"Sawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Ruth","family":"Wu-Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-wu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry L.","family":"Wessale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genta","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.10.008_bib0005","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1523-1755.2005.09501.x","article-title":"Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease","volume":"95","author":"Silver","year":"2005","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0010","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsbmb.2016.10.008_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000420167","article-title":"The noncalcemic analogue of vitamin D 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion","volume":"91","author":"Nishii","year":"1991","journal-title":"Contrib. Nephrol."},{"issue":"5 Suppl. 5","key":"10.1016\/j.jsbmb.2016.10.008_bib0020","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1053\/ajkd.2001.28109","article-title":"Vitamin D analogues for the management of secondary hyperparathyroidism","volume":"38","author":"Martin","year":"2001","journal-title":"Am. J. Kidney Dis."},{"issue":"2 Suppl. 2","key":"10.1016\/j.jsbmb.2016.10.008_bib0025","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1053\/ajkd.1998.v32.pm9808142","article-title":"Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats","volume":"32","author":"Slatopolsky","year":"1998","journal-title":"Am. J. Kidney Dis."},{"issue":"2b","key":"10.1016\/j.jsbmb.2016.10.008_bib0030","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1476-5381.2011.01473.x","article-title":"VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects","volume":"164","author":"Wu-Wong","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.10.008_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2014.12.002","article-title":"Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5\/6 nephrectomized rats","volume":"148","author":"Wu-Wong","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.10.008_bib0040","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00129.2014","article-title":"Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5\/6 nephrectomized rats","volume":"308","author":"Wu-Wong","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"21","key":"10.1016\/j.jsbmb.2016.10.008_bib0045","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1016\/j.bmcl.2013.08.076","article-title":"Synthesis of VS-105: a novel and potent vitamin D receptor agonist with reduced hypercalcemic effects","volume":"23","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.2008.568","article-title":"Suppression of parathyroid hormone production in vitro and in vivo by RNA interference","volume":"75","author":"Kanai","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2016.10.008_bib0055","first-page":"1","article-title":"Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis","volume":"2010a","author":"Wu-Wong","year":"2010","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","article-title":"Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies","volume":"165","author":"van Ballegooijen","year":"2013","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.10.008_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","article-title":"Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study","volume":"11","author":"Kamycheva","year":"2004","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.10.008_bib0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.10.008_bib0080","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000088295","article-title":"Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis","volume":"102","author":"Kim","year":"2006","journal-title":"Nephron Clin. Pract."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.10.008_bib0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jrn.2006.07.006","article-title":"Impact of kidney bone disease and its management on survival of patients on dialysis","volume":"17","author":"Lee","year":"2007","journal-title":"J. Ren. Nutr."},{"issue":"10","key":"10.1016\/j.jsbmb.2016.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.10.008_bib0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.10.008_bib0100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1681\/ASN.2007091002","article-title":"Impact of activated vitamin D and race on survival among hemodialysis patients","volume":"19","author":"Wolf","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.10.008_bib0105","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01760408","article-title":"Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients","volume":"3","author":"Shinaberger","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.10.008_bib0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-Diaz","year":"2008","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.jsbmb.2016.10.008_bib0115","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.10.008_bib0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2016.10.008_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.ajkd.2008.06.023","article-title":"Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort","volume":"52","author":"Levin","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.jsbmb.2016.10.008_bib0130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2016.10.008_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00467-010-1526-x","article-title":"Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug?","volume":"26","author":"Biggar","year":"2011","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.jsbmb.2016.10.008_bib0140","doi-asserted-by":"crossref","first-page":"c187","DOI":"10.1159\/000317198","article-title":"The effects of vitamin D therapy on left ventricular structure and function\u2014are these the underlying explanations for improved CKD patient survival?","volume":"116","author":"Covic","year":"2010","journal-title":"Nephron Clin. Pract."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.10.008_bib0145","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsbmb.2016.10.008_bib0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0155","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jsbmb.2016.10.008_bib0160","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.ajkd.2007.12.038","article-title":"Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial","volume":"51","author":"Szeto","year":"2008","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2016.10.008_bib0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jsbmb.2016.10.008_bib0170","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/endo.132.6.8389284","article-title":"Interaction between calcium and 1 25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids","volume":"132","author":"Russell","year":"1993","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2016.10.008_bib0175","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo.136.4.7895652","article-title":"The roles of calcium and 1 25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands","volume":"136","author":"Brown","year":"1995","journal-title":"Endocrinology"},{"issue":"33","key":"10.1016\/j.jsbmb.2016.10.008_bib0180","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D","volume":"277","author":"Canaff","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.10.008_bib0185","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1046\/j.1523-1755.2001.59780182.x","article-title":"Blunted response to vitamin D in uremia","volume":"78","author":"Glorieux","year":"2001","journal-title":"Kidney Int. Suppl."},{"issue":"9","key":"10.1016\/j.jsbmb.2016.10.008_bib0190","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.jsbmb.2016.10.008_bib0195","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016302916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016302916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:54:43Z","timestamp":1760745283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016302916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":39,"alternative-id":["S0960076016302916"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.10.008","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5\/6 nephrectomized rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}